An exceptional AIM company continues to deliver
Results and updates covered here include excellent results from a high performing AIM company, which has delivered exceptional returns since arriving on the stock market a decade ago; can it continue to deliver? Elsewhere, we are puzzled by the reaction to in-line numbers from another high-quality AIM company. Read on here for more on this and other news from small caps and AIM. (Free to read)
Advanced Medical: some aspect has upset the market Advanced Medical Solutions (AIM: AMS), the specialist in tissue-healing technologies, announced what at first glance appeared to be decent results for the year ending 31 December 2022. However, there was something in the detail which clearly upset the market, driving the shares down. We consider this below, while our earlier premium commentary here: ‘IHT planning favourite is looking more encouraging’ took an in-depth look at this popular AIM business. The headlines from the latest results looked good with revenue of £124.3m an increase of 14% or 10% at constant currency, adjusted profit…